Seki Y, Samejima N, Komatsuzaki A
Department of Neurosurgery, Tokyo Kyosai Hospital, Tokyo, Japan.
Acta Neurochir Suppl. 2007;97(Pt 2):431-5. doi: 10.1007/978-3-211-33081-4_49.
In this article, the authors describe the current state of the auditory brainstem implant (ABI), comparing it to that of the cochlear implant (CI). The CI restores hearing by stimulating the cochlear nerve in the cochlea in patients whose deafness has been caused by inner ear disease; the ABI restores hearing by stimulating the cochlear nucleus of the brainstem in patients who are deaf because of bilateral cochlear nerve dysfunction. Up to now, about 500 patients worldwide have undergone ABI and had their hearing restored, most of whom suffer from neurofibromatosis type 2. Hearing performance, however, is not as good as that offered by the cochlear implant. To improve the quality of hearing, new techniques such as advanced coding strategies and penetrating electrodes, are now being introduced.
在本文中,作者描述了听觉脑干植入物(ABI)的现状,并将其与人工耳蜗(CI)进行了比较。人工耳蜗通过刺激因内耳疾病导致失聪患者耳蜗中的蜗神经来恢复听力;听觉脑干植入物则通过刺激因双侧蜗神经功能障碍而失聪患者脑干中的蜗神经核来恢复听力。到目前为止,全球约有500名患者接受了听觉脑干植入并恢复了听力,其中大多数患有2型神经纤维瘤病。然而,其听力表现不如人工耳蜗。为了提高听力质量,目前正在引入先进编码策略和穿透电极等新技术。